GCB

Portfolio · 1

Epitomee Medical

Drug-free Capsules for Diabetes Prevention and Weight Loss

1 round $8.0M committed Latest: 2019-04

Investment activity

1 portfolio exit on record.

Q&A

What is GCB's primary sector focus for investments?

GCB primarily focuses on the Health Tech & Life Sciences sector, with all its recorded portfolio companies and exits falling within this area.

Can you provide an example of a notable exit for GCB?

GCB had a notable exit in December 2021 with Epitomee Medical, which went public on the TASE with a valuation of $203M. Epitomee Medical had raised $60M in capital prior to its IPO.

When did GCB make its most recent recorded investment?

GCB's most recent recorded investment was in April 2019.

Which portfolio company has GCB exited?

GCB has exited Epitomee Medical, a company focused on drug-free capsules for diabetes prevention and weight loss.

What is the funding stage of GCB's portfolio company, Epitomee Medical?

Epitomee Medical, a GCB portfolio company, is currently public.

Where is GCB headquartered?

GCB is headquartered in Ireland.